title: Letter: usefulness of HCC risk scores in HCV patients who fail pegylated interferon/ribavirin.
authors.affiliation: Division of Hepato-Gastroenterology, Department of Internal Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
authors.forename: T-M
authors.initials: TM
authors.lastname: Chen
authors.affiliation: Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. cshy333@csh.org.tw.|Division of Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. cshy333@csh.org.tw.
authors.forename: C-C
authors.initials: CC
authors.lastname: Lin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D011788:Quality of Life
chemical_list: D000998:Antiviral Agents